Skip directly to search Skip directly to A to Z list Skip directly to site content
CDC Home

Volume 16, Number 6—June 2010

Dispatch

Rhinovirus C and Respiratory Exacerbations in Children with Cystic Fibrosis

Marina B. de AlmeidaComments to Author , Rodrigo M. Zerbinati, Adriana F. Tateno, Cristina M. Oliveira, Renata M. Romão, Joaquim C. Rodrigues, Cláudio S. Pannuti, and Luiz Vicente F. da Silva FilhoComments to Author 
Author affiliations: Hospital das Clínicas da Faculdade de Medicina de Universidade de São Paulo, São Paulo, Brazil (M.B. de Almeida, J.C. Rodrigues, L.V.F. da Silva Filho); Universidade de São Paulo, São Paulo (R.M. Zerbinati, A.F. Tateno, C.M. Oliveira, R.M. Romão, C.S. Pannuti, L.V.F. da Silva Filho)

Main Article

Table 2

Virologic test results and respiratory exacerbation outcome for 103 children with cystic fibrosis, Brazil, 2006–2007*

Virus OR (95% CI) p value
Any respiratory virus 1.063 (0.979–1.154) 0.144
Rhinovirus 1.020 (0.931–1.117) 0.666
Any respiratory virus except rhinoviruses 1.195 (1.043–1.369) 0.010
Rhinovirus A2 or C (excluding samples not sequenced) 1.213 (1.024–1.436) 0.025

*Estimates from binomial, generalized linear models. OR, odds ratio; CI, confidence interval.

Main Article

Top of Page

USA.gov: The U.S. Government's Official Web PortalDepartment of Health and Human Services
Centers for Disease Control and Prevention   1600 Clifton Rd. Atlanta, GA 30333, USA
800-CDC-INFO (800-232-4636) TTY: (888) 232-6348 - Contact CDC–INFO